About the Handling of Personal Information
At PDRadiopharma Inc. we disclose the following information regarding our handling of personal information as the "business operator handling personal information" as specified by the relevant laws. To use personal information including "My Numbers (individual numbers and specific personal information)," please refer to the "Basic policy on proper handling of individual numbers and specific personal information."
Purposes for using personal information
We use personal information for research, development, manufacturing, sale, and other businesses of drugs and medical devices (hereinafter called "drugs, etc.") in our company as follows.
There may be other cases where we report an additional purpose of using personal information by releasing a notification or announcement.
- Purposes of using the personal information of physicians, dentists, nurses, radiation technologists, pharmacists, pharmacy and drugstore personnel, other healthcare professionals, and researchers in medicine, pharmacy, and related fields
- Provision and collection of information related to the proper use of drugs, etc.
- Provision and collection of information related to the quality, safety, and efficacy of drugs, etc.
- Research in the fields of medicine and pharmacy
- Provision, collection, and evaluation of medical and academic information
- Operation or support of a website for healthcare professionals
- Sponsoring and implementation of clinical trials, post-marketing surveillance, etc.
- Communication and provision of information to product marketing authorization holders, manufacturers and distributors, healthcare providers, etc.
- Notification or report to government agencies
- Purposes of using the personal information of inquirers about our products, etc. and users of our other contact points
- Assessments, investigations, and responses regarding consultations and reports
- Communication and provision of information to product marketing authorization holders, manufacturers and distributors, healthcare providers, etc.
- Notification or report to government agencies
- Purposes of the personal information of job applicants
- Sending corporate information, etc.
- Recruitment screening and selection
- Communications regarding selection procedures and results
- Communications regarding pre-employment procedures and other matters
- Review and analysis of our recruitment activities, as well as learning for future recruitment activities
- Purposes of the personal information of executives, employees (including retirees), and their families
- Management of work hours, payroll, human resources, performance evaluations, talent development, employee benefits, and occupational safety and health
- Communications and provision of information to the health insurance association and relevant companies
- Notification or report to government agencies
- Sending corporate information
- Purposes of the personal information of our business partners
- Preparation, implementation, and management of transactions
- Notifications, reports, and other interactions with government agencies
Joint use of personal information by our company
We may jointly use personal information that you submit, as described below.
- Items of personal information that may be used jointly:
Name, information regarding affiliation (company name, department name, etc.), job title, address, phone number, fax number, email address, voice recordings, and history of product purchases (including leases and rentals) and service usage - Scope of joint use:
PeptiDream Inc. - Purposes of joint use:
The scope required to achieve the purposes notified or publicly announced at the time the personal information was obtained - Administrator of personal information that may be used jointly:
PDRadiopharma Inc. (our company)
Address: Kanematsu Building, 14-1, Kyobashi 2-Chome, Chuo-ku, Tokyo 104-0031, Japan
Representative: Masato Murakami, Representative Director, President
- Business partner:
Eli Lilly Japan K.K.
Business partnership for AMYViD® Injection (nonproprietary name: florbetapir (F18) (hereinafter referred to as "Product") - Items of personal information that may be used jointly:
Personal data regarding medical professionals, including physicians, dentists, veterinarians, pharmacists, clinical laboratory technologists, radiologic technologists, and nurses, as well as researchers in the fields of medicine and pharmacy and journalists, covering the following items- name, gender, employer name, employer address, employer phone number, medical specialty, email address, year and institution of graduation, type of practice, media outlet name, and other items necessary to achieve the purposes of use listed below
- Scope of joint use:
PDRadiopharma Inc. and Eli Lilly Japan K.K. - Purposes of joint use:
- Provision of the Product
- Provision and collection of information related to proper use, quality, safety, and other information about the Product
- Provision, collection, and analysis of usage status, usage patterns, and usage needs and other marketing information about the Product
- Provision, collection, and evaluation of medical information and other business-related information
- Implementation of clinical trials, post-marketing surveillances, and other business-related researches/studies
- Notification or report in accordance with laws and other standards
- Provision of information to third parties in the scope necessary to execute the above
- Administrator of personal information that may be used jointly:
PDRadiopharma Inc. (our company)
Address: Kanematsu Building, 2-14-1, Kyobashi, Chuo-ku, Tokyo 104-0031, Japan
Representative: Masato Murakami, Representative Director, President
Eli Lilly Japan K.K.
(The address and the representative's name are listed on the website of Eli Lilly Japan K.K.)